Side effects of chemotherapy among cancer patients in a Malaysian general hospital: Experiences, perceptions and informational needs from clinical pharmacists

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5305-5309

  Chan, Huan Keat ^a   Ismail, Sabrina ^a  

^a HOSPITAL SULTANAH BAHIYAH   (Malaysia)

Author keywords

Cancer informational needs; Chemotherapy side effects; Malaysia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; CROSS-SECTIONAL STUDY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GENERAL HOSPITAL; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; MALAYSIA; MALE; MIDDLE AGED; NEOPLASMS; PHARMACIST; YOUNG ADULT;

ADULT; ANTINEOPLASTIC AGENTS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALS, GENERAL; HUMANS; MALAYSIA; MALE; MIDDLE AGED; NEOPLASMS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; YOUNG ADULT;

EID: 84905375452     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5305     Document Type: Article

References (37)

1. Aranda S, Jefford M, Yates P, et al. (2012). Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trial. Ann Oncol, 23, 222-31.
2. Ashing-Giwa KT, Lim JW (2009). Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum, 36, 79-88.
3. Arslan FT, Basbakkal Z, Kantar M (2013). Quality of life and chemotherapy-related symptoms of Turkish cancer children undergoing chemotherapy. Asian Pac J Cancer Prev, 14, 1761-8.
4. Bonnabry P, Cingria L, Ackermann M (2006). Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care, 18, 9-16.
5. Carelle N, Piotto E, Bellanger A, et al. (2002). Changing patient perceptions of the side effects of cancer chemotherapy. Cancer, 95, 155-63.
6. Coates A, Abraham S, Kaye SB, et al. (1983). On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol, 19, 203-8.
7. Coutsouvelis J, Corallo CE, Dooley MJ, Foo J, Whitfield A (2010). Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care unit. Support Care Cancer, 18, 811-6.
8. Dohler N, Krolop L, Ringsdorf S, et al. (2011). Task allocation in cancer medication management-integrating the pharmacist. Patient Educ Couns, 83, 367-74.
9. Farrell C, Brearley SG, Pilling M, Molassiotis A (2013). The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life. Support Care Cancer, 21, 59-66.
10. Ghandhi TK, Bartel SB, Shulman LN, et al. (2005). Medication safety in the ambulatory chemotherapy setting. Cancer, 104, 2477-83.
11. Goldspiel BR, DeChristoforo R, Daniels CE (2000). A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm, 57, S4-9.
12. Griffin AM, Butow PN, Coates AS (1996). On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol, 7, 189-95.
13. International Agency sor Research on Cancer (IARC) (2012). Globocan 2012: Estimated cáncer incidence, mortality and prevalence worldwide in 2012. Available at http:// globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (last accessed on 30 Jan 2014).
14. Ismail F, Mohamed AK, Lim KH (2011). Systemic Therapy of Cancer, 3rd edition. The Ministry of Health, Kuala Lumpur pp 75-8.
15. Jordan K, Schmoll HJ, Aapro MS (2007). Comparative activity of antiemetic drugs. Oncol Hemato, 61, 162-75.
16. Kayl AE, Meyers CA (2006). Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol, 18, 24-8.
17. Kessels RP (2003). Patients' memory for medical information. J R Soc Med, 96, 219-22.
18. Kim IR, Cho J, Choi EK, et al. (2012). Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer Prev, 13, 1383-8.
19. Lee YM, Francis K, Walker J, Lee SM (2004). What are the information needs of Chinese breast cancer patients receiving chemotherapy? Eur J Oncol Nurs, 8, 224-33.
20. Lei CP, Har YC, Abdullah KL (2011). Informational needs of breast cancer patients on chemotherapy: differences between patients' and nurses' perceptions. Asian Pac J Cancer Prev, 12, 797-802.
21. Lemieux J, Maunsell E, Provencher L (2008). Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology, 17, 317-28.
22. Lihara H, Ishihara M, Matsuura K, et al. (2012). Pharmacists contribute to the improve efficiency of medical practices in the outpatient cancer chemotherapy. J Eval Clin Pract, 18, 753-60.
23. Lopez V, Copp G, Brunton L, Molassiotis A (2011). Symptom experience in patients with gynecological cancers: the development of symptom cIusters through patient narratives. J Support Oncol, 9, 64-71.
24. Meirow D, Nugent D (2001). The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 7, 535-43.
25. Molassiotis A, Coventry PA, Stricker CT, et al. (2007). Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage, 34, 148-59.
26. Naing L, Winn T, Rusli BN (2006). Practical issues in calculating the sample size for prevalence studies. Archiv Orofacial Sci, 1, 9-14.
27. Partridge AH, Burstein HJ, Winer EP (2001). Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr, 30, 135-42.
28. Paice JA (2007). Chemotherapy-induced peripheral neuropathy: A dangerous but understudied syndrome. Pain Management SIG Newsletter, 17.
29. Piredda M, Rocci L, Gualandi R, et al. (2008). Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy. Eur J Oncol Nurs, 12, 120-6.
30. Schnell FM (2003). Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist, 8, 187-98.
31. Shapiro CL, Recht A (2001). Side effects of adjuvant treatment of breast cancer. N Engl J Med, 344, 1997-2008.
32. Sun CC1, Bodurka DC, Donato ML, et al. (2002). Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol, 87, 118-28.
33. Sun CC, Bodurka DC, Weaver CB, et al. (2005). Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer, 13, 219-27.
34. Torpy JM, Lynm C, Glass RM (2010). JAMA patient page. Cancer: the basics. JAMA, 303, 1108.
35. The Ministry of Health, Malaysia (2007). National Cancer Registry Report. Malaysia Cancer Statistics - Data and Figure 2007. Available at http://www.makna.org.my/ PDF/MalaysiaCancerStatistics2007.pdf (last accessed on 30 Jan 2014).
36. Tuffaha HW, Abdelhadi O, Omar SA (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. Int J Clin Pharm, 34, 27-31.
37. Valgus JM, Faso A, Gregory KM, et al (2011). Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center. Am J Health Syst Pharm, 68, 613-9.